<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005223A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005223</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13874762</doc-number><date>20130501</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><priority-claims><priority-claim sequence="01" kind="national"><country>GB</country><doc-number>1207701.2</doc-number><date>20120502</date></priority-claim><priority-claim sequence="02" kind="national"><country>GB</country><doc-number>1221130.6</doc-number><date>20121123</date></priority-claim></priority-claims><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>31</main-group><subgroup>454</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>31</main-group><subgroup>454</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>514326</main-classification></classification-national><invention-title id="d0e79">ALFENTANIL COMPOSITION FOR THE TREATMENT OF ACUTE PAIN</invention-title><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Orexo AB</last-name><address><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Pettersson</last-name><first-name>Anders</first-name><address><city>Kode</city><country>SE</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Johansson</last-name><first-name>Barbro</first-name><address><city>Uppsala</city><country>SE</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Schwan</last-name><first-name>Emil</first-name><address><city>Uppsala</city><country>SE</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>Orexo AB</orgname><role>03</role><address><city>Uppsala</city><country>SE</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">There is provided pharmaceutical compositions for the treatment of pain e.g. short-term pain, which compositions comprise a mixture comprising:<ul id="ul0001" list-style="none">    <li id="ul0001-0001" num="0000">    <ul id="ul0002" list-style="none">        <li id="ul0002-0001" num="0000">(a) microparticles of alfentanil, or a pharmaceutically acceptable salt thereof, which microparticles are presented on the surfaces of larger carrier particles;</li>        <li id="ul0002-0002" num="0000">(b) a water-soluble weak base; and</li>        <li id="ul0002-0003" num="0000">(c) a compound which is a weak acid, which acid is presented in intimate mixture with the microparticles of alfentanil or salt thereof.<br/>The composition may further comprise a disintegrant. The acid is preferably citric acid.</li>    </ul>    </li></ul></p></abstract></us-patent-application>